Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beta-Lactam Dose Optimisation in the Intensive Care Unit: Targets, Therapeutic Drug Monitoring and Toxicity
Amy Legg, Sinead Carmichael, Ming G. Chai, et al.
Antibiotics (2023) Vol. 12, Iss. 5, pp. 870-870
Open Access | Times Cited: 20

Showing 20 citing articles:

Probiotics and Their Bioproducts: A Promising Approach for Targeting Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus
Manav Jain, Gideon Stitt, Luke Son, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2393-2393
Open Access | Times Cited: 20
Unraveling the impact of therapeutic drug monitoring via machine learning for patients with sepsis
H. Ceren Ates, Abdallah Alshanawani, Stefan Hagel, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101681-101681
Open Access | Times Cited: 5
Plasma Concentrations of Benzylpenicillin and Cloxacillin in Infective Endocarditis—With Special Reference to Delayed Hypersensitivity Reactions
Maria Hägglund, Ulrika Snygg‐Martin, Lars Olaison, et al.
Antibiotics (2025) Vol. 14, Iss. 1, pp. 56-56
Open Access
Individualization of piperacillin dosage based on therapeutic drug monitoring with or without model-informed precision dosing: a scenario analysis
David Haefliger, Leonardo Mina, Monia Guidi, et al.
Journal of Antimicrobial Chemotherapy (2025)
Open Access
Short, extended and continuous infusion of β-lactams: predicted impact on target attainment and risk for toxicity in an ICU patient cohort
Anna-Karin Smekal, Maria Swartling, Mia Furebring, et al.
Journal of Antimicrobial Chemotherapy (2025)
Open Access
Higher target attainment for B-lactam antibiotics in patients with Gram-negative bloodstream infections when four times actual minimum inhibitory concentrations and epidemiological cutoff values are applied compared to clinical breakpoints
Ilja Areskog Lejbman, Gustav Torisson, Fredrik Resman, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2025)
Open Access
Beta‐lactam antibiotic concentrations in critically ill patients with standard and adjusted dosages: A prospective observational study
Ilja Areskog Lejbman, Gustav Torisson, Fredrik Resman, et al.
Acta Anaesthesiologica Scandinavica (2024) Vol. 68, Iss. 4, pp. 530-537
Open Access | Times Cited: 2
A case report of treatment of a streptococcal brain abscess with ceftobiprole supported by the measurement of drug levels in the cerebrospinal fluid
Simone Giuliano, Jacopo Angelini, Sarah Flammini, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27285-e27285
Open Access | Times Cited: 2
Antibiotic dose optimisation in the critically ill: targets, evidence and future strategies
Christopher J. Dyer, Jan J. De Waele, Jason A. Roberts
Current Opinion in Critical Care (2024) Vol. 30, Iss. 5, pp. 439-447
Closed Access | Times Cited: 2
Role of microsomal metabolism in bromfenac-induced cytotoxicity
Jang Su Jeon, Hyemin Kim, Seongyea Jo, et al.
Chemico-Biological Interactions (2024) Vol. 391, pp. 110903-110903
Closed Access | Times Cited: 1
Impact of Continuous Infusion Meropenem PK/PD Target Attainment on C-Reactive Protein Dynamics in Critically Ill Patients With Documented Gram-Negative Hospital-Acquired or Ventilator-Associated Pneumonia
Carla Troisi, Pier Giorgio Cojutti, Matteo Rinaldi, et al.
Clinical Pharmacokinetics (2024)
Open Access | Times Cited: 1
Improving cefazolin exposure in critically ill children using a population pharmacokinetic model
Clémence Rivaud, Mehdi Oualha, Elodie Salvador, et al.
British Journal of Clinical Pharmacology (2024)
Open Access
The OPAT opportunity for beta-lactam individualization
Lindsey M. Childs‐Kean, Christina G. Rivera, Veena Venugopalan, et al.
Antimicrobial Stewardship & Healthcare Epidemiology (2024) Vol. 4, Iss. 1
Open Access
Therapeutic drug monitoring-guided piperacillin dosing in critically ill patients undergoing continuous renal replacement therapy: a systematic review
Nazatul Adhwa Mohd Rozi, Nor Asyikin Mohd Tahir, Shamin Mohd Saffian, et al.
Journal of Antimicrobial Chemotherapy (2024)
Closed Access
Serum Concentration at 24 h With Intensive Beta‐Lactam Therapy in Sepsis and Septic Shock: A Prospective Study
Elizabeth Theriault, M. Benali, Samuel Starnino, et al.
Critical Care Research and Practice (2024) Vol. 2024, Iss. 1
Open Access
Is it a case of higher, the worse, or are beta-lactam antibiotics the innocent bystanders?
Aaron J. Heffernan, Jason A. Roberts
Journal of Critical Care (2024) Vol. 85, pp. 154934-154934
Closed Access
Resistance Optimised Antibiotic Dosing (The ROAD Study): Is dosing of meropenem and piperacillin-tazobactam optimised to prevent the emergence of antibiotic resistance safe and feasible in the ICU? A pilot study.
Jason A. Roberts, Aaron J. Heffernan, Min Chai, et al.
CMI Communications (2024) Vol. 2, Iss. 1, pp. 105051-105051
Open Access
Unraveling the Impact of Therapeutic Drug Monitoring via Machine Learning
H. Ceren Ates, Abdallah Alshanawani, Stefan Hagel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Antibiotic-induced neurological adverse drug reactions
Clémence Lacroix, Tessa Pietri, Vincent Montero, et al.
Therapies (2023) Vol. 79, Iss. 2, pp. 181-188
Closed Access
Pharmacokinetics of biapenem in critically ill patients
S. К. Zyryanov, О. И. Бутранова, А. М. Казанова
Clinical Microbiology and Antimicrobial Chemotherapy (2023) Vol. 25, Iss. 3, pp. 260-265
Open Access
Page 1

Scroll to top